Katarina Carlsson-Steen
Medicon Village
Lund, M 22381, Sweden
Lund, M 22381, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
FOCU.SE trial: a nationwide Swedish drug repurposing protocol and research framework.
Journal: Acta oncologica (Stockholm, Sweden)
Published: January 23, 2026
A conceptual health economic modelling framework to assess the cost-effectiveness of molecular target-driven treatment regimens in oncology.
Journal: Acta oncologica (Stockholm, Sweden)
Published: November 24, 2025
Comorbidity and Mortality in Men and Women With Haemophilia in Three Nordic Countries-Comparisons to Matched Controls.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: November 20, 2024
Brief admission by self-referral as an add-on to usual care for individuals with self-harm at risk of suicide: cost-effectiveness and 4-year health-economic consequences after a Swedish randomized controlled trial.
Journal: Nordic journal of psychiatry
Published: June 14, 2024
PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe.
Journal: Acta oncologica (Stockholm, Sweden)
Published: December 22, 2023
Atherosclerotic Cardiovascular Disease in Type 2 Diabetes: A Retrospective, Observational Study of Economic and Clinical Burden in Sweden.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: March 03, 2023
Economic burden of atherosclerotic cardiovascular disease: a matched case-control study in more than 450,000 Swedish individuals.
Journal: BMC cardiovascular disorders
Published: November 23, 2022
High use of pain, depression, and anxiety drugs in hemophilia: more than 3000 people with hemophilia in an 11-year Nordic registry study.
Journal: Research and practice in thrombosis and haemostasis
Published: August 25, 2022
Burden of established cardiovascular disease in people with type 2 diabetes and matched controls: Hospital-based care, days absent from work, costs and mortality.
Journal: Diabetes, obesity & metabolism
Published: August 10, 2022
Model-based predictions on health benefits and budget impact of implementing empagliflozin in people with type 2 diabetes and established cardiovascular disease.
Journal: Diabetes, obesity & metabolism
Published: August 10, 2022
The implementation of a noninvasive lymph node staging (NILS) preoperative prediction model is cost effective in primary breast cancer.
Journal: Breast cancer research and treatment
Published: January 21, 2022
Last Updated: 09/26/2026